Combining methylphenidate and clonidine: a clinically sound medication option.
Wilens
T E
TE
Pediatric Psychopharmacology Unit, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA.
Spencer
T J
TJ
Swanson
J M
JM
Connor
D F
DF
Cantwell
D
D
D000293:Adolescent; D016907:Adverse Drug Reaction Reporting Systems; D000374:Aggression; D000959:Antihypertensive Agents / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D002648:Child; D002669:Child Welfare; D003000:Clonidine / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D008774:Methylphenidate / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D012449:Safety
D000959:Antihypertensive Agents; D000697:Central Nervous System Stimulants; D008774:Methylphenidate; D003000:Clonidine